Fidelity EUR Corporate Bond Research Enhanced UCITS ETF Acc
Fidelity EUR Corporate Bond Research Enhanced
- ISIN
- IE000JEXZJT1
- Issuer
- Fidelity ETF
- TER
- 0.03%
- Latest closing price
- N/A
- Fund Size
- €53 m As of: Sep 30, 2026
- Domicile
- Ireland
- Distribution Policy
- Accumulating
- Replication Method
- Physical
- Base Currency
- EUR
- WKN / Ticker
- A41FKG / FBIE
Data availability
Data is available for 2 of 5 areas for this fund.
- Master data (TER, index, size): As of: Sep 30, 2026
- Closing price: not available
- Price history (at least 20 prices): not available
- Holdings: As of: Jul 31, 2026
- Risk figures: not available
Missing information is marked as “not available” and is not estimated. The issuer’s documents are authoritative.
At a glance
Fidelity EUR Corporate Bond Research Enhanced UCITS ETF Acc (ISIN IE000JEXZJT1) is a fund from Fidelity ETF (fund type: ETF). Benchmark index: Fidelity EUR Corporate Bond Research Enhanced. Its ongoing charges (TER) are 0.03% per year. The fund size is €53 m. Distribution policy: Accumulating. Replication: Physical. Fund domicile: Ireland.
- Launch date 27.01.2026 (less than 1 year)
- Number of Holdings 140
- Strategy Actively managed
- Base Currency EUR
- Currency hedging No
- Distribution Policy Accumulating
- Replication Method Physical
- Securities lending No
- Domicile IE
- UCITS Compliant Yes
Price development
Pure price change based on stored closing prices; distributions, purchase costs and taxes are not included. Different currencies and index types (price or total return index) can distort the comparison line. Past performance is not a reliable indicator of future results.
Risk figures (12 months)
No calculated risk figures are available for this fund yet.
The official summary risk indicator (SRI, scale 1–7) is in the issuer’s key information document (KID). The figures here are historical values and do not replace it.
Documents
We have no documents stored for this fund. The key information document (KID), factsheet and prospectus are provided by the issuer.
Tracking difference and tracking error
We have no comparison series stored for this fund’s index, so a tracking analysis is not possible.
What does the fund invest in?
As of 31.07.2026 · Source: justETF / etfdbSector Breakdown
-
Financials 47.2%
-
Industrials 13.7%
-
Health care 8.2%
-
Technology 6.2%
-
Basic materials 4.6%
-
Utilities 4.4%
-
Consumer staples 4.1%
-
Energy 3.3%
-
Telecommunication 3.3%
-
Consumer discretionary 2.9%
-
Other 2.3%
Country Breakdown
-
United States 20.1%
-
France 16.8%
-
Other 10.3%
-
Germany 8.4%
-
United Kingdom 6.3%
-
Netherlands 6.3%
-
Sweden 5.2%
-
Spain 4.9%
-
Austria 4.2%
-
Denmark 3.0%
-
All others 14.6%
Holdings
Showing 10 holdings that together make up 10.6 % of fund assets. (out of 140 holdings in total).
| # | Name | ISIN | Sector | Country | Weight |
|---|---|---|---|---|---|
| 1 | BNP Paribas, 2.88% 6may2030, EUR (20315) | FR001400ZE74 | – | – | 1.12 % |
| 2 | Bouygues, 1.125% 24jul2028, EUR | FR0013507654 | – | – | 1.09 % |
| 3 | Cofiroute, 3.125% 6mar2033, EUR | FR001400T0B0 | – | – | 1.09 % |
| 4 | Novo Nordisk, 2.375% 27may2028, EUR | XS3002552993 | – | – | 1.08 % |
| 5 | JDE Peets, 1.125% 16jun2033, EUR | XS2354444379 | – | – | 1.05 % |
| 6 | Mastercard, 1% 22feb2029, EUR | XS2448014808 | – | – | 1.04 % |
| 7 | The Coca-Cola Company, 1% 9mar2041, EUR | XS2307864020 | – | – | 1.03 % |
| 8 | AstraZeneca, 0.375% 3jun2029, EUR (9) | XS2347663507 | – | – | 1.03 % |
| 9 | NatWest Group, 3.24% 13may2030, EUR (3528) | XS3069320474 | – | – | 1.03 % |
| 10 | Goldman Sachs, 3.984% 18dec2036, EUR (F-1179) | XS3255333315 | – | – | 1.03 % |
Cost calculator
What does this ETF cost you per year – and over your whole investment horizon?Simplified model based on the TER, excluding order fees, spreads, taxes and tracking difference. Not investment advice.
Alternatives on the same index
Other ETFs tracking the Fidelity EUR Corporate Bond Research Enhanced – cheapest first.Frequently asked questions about the Fidelity EUR Corporate Bond Research Enhanced UCITS ETF Acc
All information without guarantee. It is provided for information purposes only and does not constitute investment advice.